ACETYLDIGOXIN
Acetyldigoxin is a semisynthetic cardiac glycoside that enhances cardiac output via Na⁺/K⁺‑ATPase inhibition. Used for heart failure and atrial arrhythmias, it offers predictable absorption. Risks include arrhythmias, GI upset, fatigue, and toxicity, especially in renal impairment.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Acetyldigoxin is a semi‑synthetic derivative of digoxin in which an acetyl group is introduced to modify pharmacokinetic behaviour. Like digoxin, it inhibits the myocardial sodium–potassium ATPase pump, increasing intracellular calcium and producing a positive inotropic effect while also influencing autonomic tone at the atrioventricular node.
Benefits and advantages
Acetyldigoxin has been used as an alternative oral cardiac glycoside with slightly different absorption and distribution characteristics compared with digoxin. It can be formulated to achieve more predictable plasma levels in some patients and is of interest for comparative pharmacology and generic development.
Side effects and risks
Adverse effects are similar to those of other digitalis glycosides and include nausea, vomiting, anorexia, dizziness, confusion and a spectrum of brady- and tachyarrhythmias that may be life‑threatening. The risk is heightened by renal impairment, electrolyte imbalance or interacting drugs. The raw material should therefore be handled only in specialised facilities with appropriate containment.
Datasheet
| Molecular Formula | C43H66O15 |
|---|---|
| Molecular Weight | 823.0 g/mol |
| CAS Number | 5511-98-8 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | alpha-Acetyldigoxin; 5511-98-8; Acetyldigoxin; Lanatilin; Sandolanid |
| IUPAC/Chemical Name | [(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-3-hydroxy-2-methyloxan-4-yl] acetate |
| InChl Key | HWKJSYYYURVNQU-DXJNJSHLSA-N |
| InChl Code | InChI=1S/C43H66O15/c1-20-38(49)32(55-23(4)44)18-37(52-20)58-40-22(3)54-36(17-31(40)46)57-39-21(2)53-35(16-30(39)45)56-26-9-11-41(5)25(14-26)7-8-28-29(41)15-33(47)42(6)27(10-12-43(28,42)50)24-13-34(48)51-19-24/h13,20-22,25-33,35-40,45-47,49-50H,7-12,14-19H2,1-6H3/t20-,21-,22-,25-,26+,27-,28-,29+,30+,31+,32+,33-,35+,36+,37+,38-,39-,40-,41+,42+,43+/m1/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.


